Acute Flaccid Myelitis (AFM): Symptoms, Diagnosis, Treatment & Red Flags
Recognition of polio-like acute flaccid weakness, urgent MRI and specimens, neurocritical care triggers, public-health reporting, evidence gaps in immunotherapy, and rehab handover for ward teams.
Featured snippet
Acute flaccid myelitis (AFM) is an uncommon neurologic syndrome of rapid-onset flaccid limb weakness with spinal cord lesions predominantly involving gray matter / anterior horn circuitry—clinically similar to poliomyelitis despite wild poliovirus not being isolated in surveillance-era AFM cohorts. Most U.S. experience is pediatric, often following a febrile respiratory or gastrointestinal prodrome by roughly one to two weeks.
Time-critical actions: admit for neuro monitoring, protect airway early if bulbar or respiratory involvement is evolving, obtain spine and brain MRI and arrange specialist-directed laboratory work-up, and notify public health when clinical plus imaging criteria for a patient under investigation are met—management of immunomodulation remains expert consultation–dependent without proven targeted therapy.
- Treat acute flaccid limb weakness in a child as an emergency: admit, map tone/reflexes/cranial nerves, and escalate respiratory surveillance before weakness “maxes out.”
- MRI of brain and entire spine is central—early films within ~72 h can be false-negative; repeat when clinical suspicion stays high.
- Viral associations cluster around non-polio enteroviruses (EV-D68, EV-A71) and other neurotropic viruses; collect NP/OP, stool, serum, and CSF quickly with health-department coordination for national testing algorithms.
- There is no FDA-approved AFM-specific drug; IVIG, corticosteroids, and plasma exchange are not endorsed or discouraged at population level—choices hinge on neurology/infectious-disease risk–benefit framing and excluding steroid-responsive mimics.
- Operational nursing focus: objective neurological assessment skills, trending vitals when autonomic instability is reported, careful sedation planning around imaging, and clean handoffs to PICU/neuro-rehab.
⚡ Quick Facts
💡 Clinical Pearl
Normal sensation early does not reassure. AFM can preserve modalities on bedside screening while anterior horn neurons fail—clinical silence around pain/temperature changes should not delay MRI or PICU escalation when power drops or bulbar signs appear.
📋 Contents
What is Acute Flaccid Myelitis?
AFM names a polio-like illness in which patients—usually previously healthy children—develop acute flaccid weakness referable to motor neurons within spinal gray matter. U.S. surveillance after 2014 codified the entity as acute flaccid limb weakness without an alternative structural explanation coupled with neuroimaging evidence of cord involvement that includes anterior horn / gray-matter signal abnormality. Pathophysiology is thought to reflect viral injury or immune-mediated damage targeting lower motor neuron pools, producing hypo- or areflexia, hypotonia, and rapid functional loss rather than upper motor neuron spasticity.
Enterovirus D68 loomed large in several North American seasonal clusters, and mechanistic reviews summarize epidemiologic and laboratory data supporting (but not absolutely proving) causal pathways from respiratory enterovirus circulation to AFM. West Nile and other flaviviruses, selected herpesviruses, and adenoviruses appear in differential virology lists because they can injure anterior horn–pattern circuitry. Wild poliovirus has not been recovered from AFM surveillance specimens in the CDC-described U.S. experience, which remains a critical distinction for infection-control messaging and vaccination policy even when weakness looks “polio-like.”
For nurses, AFM is a coordination diagnosis: the payoff from early recognition is less about a bedside “name” and more about activating MRI-capable centers, respiratory safety nets, specialist co-management, and public-health case reporting so families receive longitudinal rehabilitation planning anchored in realistic recovery expectations.
AFM can worsen over hours—assume instability until proven otherwise.
- New hypoventilation, weak cough, stridor, or inability to handle secretions after a prodromal illness.
- Rapidly progressive flaccid weakness moving from one limb pattern to multilevel involvement or neck flexion failure.
- Hypotension/hypertension swings, arrhythmia suspicion, or temperature dysregulation hinting at autonomic cord/brainstem involvement.
- Sudden stroke syndromes remain parallel emergencies—do not anchor prematurely on AFM if focal cortical signs dominate.
Immediate actions: escalate to senior clinicians and PICU/HDU per protocol; apply continuous SpO2 and, when ordered, capnography; avoid unsupervised oral intake if swallow is untested; cluster imaging/sedation with anesthesia and neurology to limit repeated airway compromise; preserve IV access for rescue therapy; document strength and reflexes serially with timestamps.
Symptoms
Prodrome: many children report febrile upper airway or gastrointestinal illness with rhinorrhea, cough, vomiting, or diarrhea. Weakness then appears abruptly—over hours to a few days—often proximally accentuated with flaccid tone and diminished reflexes in affected limbs. Caregivers may describe a “limp arm,” dragging foot, or refusal to bear weight rather than adult-sounding “weakness.”
Cranial nerve and bulbar cues
- Facial asymmetry or eyelid droop—overlap with facial (Bell) palsy patterns prompts imaging, not reassurance.
- Dysarthria, hypophonia, dysphagia, pooling saliva, or weak cry (pediatrics)—watch for silent aspiration.
Systemic and supportive findings
- Neck stiffness, headache, or limb pain may accompany weakness—still pursue cord imaging when motor findings evolve.
- Sensory symptoms exist in a minority; “normal sensation” does not exclude AFM.
- Fatigue, generalized weakness descriptors, and dyspnea should trigger objective respiratory measurements.
Causes and Risk Factors
AFM is not one single pathogen but a clinical–radiologic syndrome. Enteroviruses dominate conversation because EV-D68 seasons temporally lined up with AFM surges in multiple countries; EV-A71 is another well-known neurotropic enterovirus. Flaviviruses such as West Nile virus, herpesviruses, and adenoviruses round out the virology differential in international guidance and CDC teaching materials. Standard respiratory precautions and specimen diligence matter while patients are immunologically vulnerable.
Modifiable vs contextual factors
- Temporal context: late-summer/early-fall clustering in the U.S. should heighten suspicion when viral prodrome precedes weakness.
- Host age: young children bear most U.S. burden—school-age mobility changes injury risk when legs fail abruptly.
- Population prevention: follow CDC non-polio enterovirus prevention messaging (hand hygiene, staying home when ill); there is no specific public intervention proven to prevent AFM individually.
How is it Diagnosed?
Diagnosis couples clinical acute flaccid limb weakness with MRI documentation of spinal gray-matter lesion(s) spanning at least one vertebral segment after alternative structural diagnoses are excluded. Advanced practice teams should perform an age-appropriate neurological assessment that explicitly grades tone, power, reflexes, cranial nerves, and respiratory reserve.
Clinical assessment
Trace symptom onset to the hour or day when possible; inventory prodromal fever, rhinorrhea, GI losses, or rashes suggestive of enteroviral exanthem. Document whether weakness is unilateral, asymmetric bilateral, or ascending. Re-check frequently—nurses often detect hand-grip changes or sitting balance loss before formal physician review.
Laboratory investigations
- CSF: cell count with differential, protein, glucose; many services add meningitis/encephalitis multiplex PCR.
- Serum: enterovirus PCR, targeted arboviral serology when geography demands, autoimmune myelitis antibodies when ordered (e.g., MOG, AQP4).
- Stool + NP/OP swabs for enterovirus PCR and respiratory multiplex—collect as close to weakness onset as logistics allow.
- Concurrent CSF glucose and protein interpretation follows institutional norms but never replaces imaging when cord involvement is suspected.
Imaging
Protocol MRI of brain and entire spinal cord with and without contrast, using the highest field strength available, is central. CDC notes early MRI within ~72 h may still be normal; repeat imaging stays on the table when clinical suspicion remains high. Brainstem cuts matter if cranial neuropathies dominate.
Diagnostic criteria / reporting nuance
Public-health case definitions (“confirmed,” “probable,” “suspect”) drive surveillance, not bedside therapeutics—yet clinicians must still report patients under investigation promptly when imaging meets gray-matter criteria even if virology is pending.
| Domain | Nursing checkpoints |
|---|---|
| Airway + ventilation | SpO2, work of breathing, cough strength, speech fatigue, GCS, suction readiness. |
| Infection prevention | Droplet/contact precautions per policy; label respiratory PCR tubes accurately. |
| Specimen logistics | Coordinate with health departments for CDC-directed shipping—do not discard surplus CSF before lab consult. |
On a small screen, swipe or scroll sideways to see the full table.
Differential Diagnoses
Flaccid weakness is never pathognomonic. Multidisciplinary teams must race through treatable surgical/vascular emergencies and immune syndromes in parallel with AFM work-up.
| Alternative | Distinguishing features |
|---|---|
| Guillain–Barré spectrum | Often ascending, may have sensory complaints; CSF albuminocytologic dissociation; nerve MRI/EMG patterns differ—managed by neurology. |
| Transverse myelitis / MOG-antibody disease | May improve with early corticosteroids—another reason not to anchor prematurely on viral AFM without imaging consultation. |
| Myasthenia gravis crisis | Fatigable ptosis, diplopia, pure motor cranial pattern—distinct therapy; still emergent. |
| Meningitis / encephalitis syndromes | Fever, meningismus, altered mentation combinations vary—CSF diagnostics and sepsis bundles may take priority briefly. |
| Spinal cord compression / epidural abscess | Pain, sphincter changes, late-night surgical triggers—MRI remains mandatory. |
| Conversion disorder | Diagnosis of exclusion after expert assessment—not a first-line nursing label. |
On a small screen, swipe or scroll sideways to see the full table.
Treatment Options
Care is triaged into supportive neurocritical care, subspecialty-led decisions about unproven immunotherapies, and early allied-health mobilization once medically safe.
First-line management (all patients)
- Admit to environments capable of escalating ventilation; many cases warrant PICU-level nursing ratios.
- Pain and anxiety control without masking neuro exams—use protocols that still allow serial strength checks.
- Nutrition, DVT prophylaxis, bowel/bladder programs per immobility risk.
Immunomodulation / plasma exchange
CDC’s expert-reviewed guidance stresses no FDA-approved AFM-specific therapy and insufficient evidence to endorse or discourage IVIG, corticosteroids, or therapeutic plasma exchange specifically for AFM. Many cohort reports describe combinations, but data are observational. Teams sometimes pursue IV methylprednisolone when autoimmune mimics remain plausible or when cord edema raises individualized concern—only under explicit specialist plans because murine EV-D68 models raised harm signals for dexamethasone in specific experimental conditions.
Therapies to avoid as AFM-targeted treatment
- Routine antivirals, interferon, or fluoxetine are not supported as AFM disease modifiers in CDC acute guidance—do not substitute them for expert consultation.
Special populations
- Adolescents and adults: rare but reported—maintain identical red-flag triage.
- Immunocompromised hosts: broaden microbiologic imagination; coordinate antimicrobial stewardship with infectious disease.
Clinical Practice Considerations
High-performing teams treat AFM as a multi-agency pathway: neurology + infectious disease + PICU + public health + rehab medicine. Nurses translate time-stamped observations into activation criteria.
Monitoring and follow-up cadence
- Acute phase (0–72 h): neuro checks per unit protocol (often hourly until stable), paired with respiratory metrics when bulbar signs exist.
- 48–96 h window: reassess need for repeat MRI if first scan normal yet weakness progresses.
- Subacute (weeks): PT/OT/SLT intensity follows rehab medicine; track joint ROM before contractures set.
- 4–12 weeks: outpatient neurology plus pulmonology if ventilator-dependent; psychology and school liaison for pediatric patients.
Escalation thresholds
- Any downward tick in vital capacity surrogates, speech intelligibility, or cough peak flow per local pulmonary standards.
- New autonomic instability with unexplained tachycardia/bradycardia or blood pressure lability.
- Inability to maintain hydration orally or signs of aspiration pneumonitis.
Interprofessional roles
- Nurses: own continuous assessment, sedation coordination, family updates, and equipment readiness (suction, NIV, intubation carts).
- Case management: anticipates home ventilator training, HMV supply, and county school accessibility paperwork.
Possible Complications
- Respiratory failure needing intubation, tracheostomy, or long-term non-invasive support.
- Neurogenic bladder/bowel, skin breakdown, heterotopic ossification risk with prolonged immobility.
- Musculoskeletal: limb-length discrepancy, scoliosis, bracing needs in growing children.
- Psychosocial: anxiety/depression in patients and caregivers adjusting to residual deficits.
Prevention
There is no individual-level intervention proven to eliminate AFM risk after routine viral exposures. Clinician-facing prevention centers on population hygiene, staying current with routine pediatric vaccinations (including polio schedule per national programme) to keep differential reasoning clean, and prompt reporting so clusters are detected early for research responsiveness.
Prognosis and Outlook
Recovery is heterogeneous: some patients regain independent ambulation; others live with lasting monoplegia, ventilator dependence, or facial asymmetry. Early intensive rehabilitation appears rational and is emphasized in CDC family materials, but realistic framing matters—motor neuron loss may be partial yet still disabling. Longitudinal neuropsychology support helps children reintegrate academically after prolonged ICU stays.
In Clinical Practice…
- When parents say “my child is clumsy today,” convert the complaint into timed maneuvers (hop, heel walk, grip, neck flexion) and compare sides.
- Use admission assessment templates to capture prodrome, travel, tick exposures, and immunization gaps without judgmental tone.
- Silence alarms only after assessing whether slowing respiratory rate is fatigue—not convenience.
- Coordinate interpreter services before signing high-stakes consent for sedation MRI in non-English-speaking families.
Bedside monitoring checklist
- Respiratory: work of breathing, SpO2, speech count, cough strength, secretion viscosity.
- Neuromuscular: grip, dorsiflexion, shoulder abduction, neck flexion; reflexes; facial symmetry.
- Autonomic: heart rate/BP variance, sweating patterns, unexplained tachycardia.
- Safety: fall precautions, assisted transfers, aspiration precautions during swallow screens.
- Vital trends: align documentation with structured vital-sign measurement routines.
When to Seek Emergency Care
Activate emergency pathways when any of the following appear new in a child or adult with suspected AFM—or when community providers identify evolving weakness before admission is arranged:
- Rising supplemental oxygen need, silent aspiration, or inability to finish sentences without breath-catching.
- Hypercapnic symptoms (morning headache, somnolence) in patients on non-invasive support.
- Hemodynamic collapse, new dysrhythmia, or seizure activity superimposed on focal deficits.
- Acute confusion with fever suggesting meningoencephalitis until proven otherwise.
Nursing Management
Pre-diagnosis and emergency department flow
- Line up MRI slot + anesthesia consult early; document last oral intake for sedation safety.
- Alert charge nurse when AFM is entertained—bed placement near higher observation ratios saves minutes.
Critical care and step-down
- Maintain escalation bundles for pending intubation; rehearse family communication scripts when escalation is likely.
- Skin and eye care for facial weakness; lubricate exposed corneas per protocol.
Rehabilitation bridges
- Teach energy-conservation pacing before discharge to ward-level independence.
- Coordinate orthotics/brace fitting appointments before weekend discharges stall.
Education, documentation, evaluation
- Use teach-back on home pulse oximetry or ventilator alarms when applicable.
- Measure success by function (distance walked, swallow safety, school attendance) not only by normalizing individual lab values.
NCLEX practice questions
These NCLEX-style clinical judgment practice items focus on the nursing priorities for this condition — recognise cues, escalate red flags, take safe action and evaluate outcomes (NCSBN Clinical Judgment Measurement Model) — through Priority FIRST, SATA, deterioration trends, multi-patient triage, ordered response, matrix matching and cloze drops on the topic of acute flaccid myelitis recognition (post-viral asymmetric weakness, MRI grey-matter cord signal), bulbar / respiratory escalation triggers and CDC reporting / supportive-care principles.
Unfolding case (Questions 1–3): Liam, 5, presents 7 days after a febrile respiratory illness with rapid-onset asymmetric flaccid weakness of the right arm and neck. Examination shows reduced tone and reflexes, intact sensation, mild dysphagia and a slightly weak cough. Vitals: T 37.4 °C, HR 112, RR 26, SpO₂ 97% RA. MRI shows long-segment T2-hyperintense grey-matter signal in the cervical cord; CSF shows lymphocytic pleocytosis.
Answer key & rationale
Does a normal MRI in the first 72 hours rule out AFM?
No. Early spinal MRI may be unrevealing; repeat imaging can be clinically justified when suspicion remains high for acute flaccid myelitis.
Who coordinates specimen shipment for AFM surveillance testing?
State or local public health departments coordinate CSF, respiratory, serum, and stool submissions per national guidance—clinical teams should not delay reporting a patient under investigation while awaiting all laboratory results.
Are corticosteroids proven to improve outcomes in AFM?
There is no FDA-approved targeted therapy for AFM and no intervention has high-quality human efficacy data; immunomodulators are sometimes discussed case-by-case with neurology and infectious disease because alternate diagnoses may require steroids.
Which bedside changes should trigger immediate respiratory escalation?
New or worsening dyspnea, weak cough, inability to count aloud, voice fatigue, swallowing failure with pooling secretions, or paradoxical breathing with accessory muscle use should trigger rapid senior review and ICU-level assessment.
How does AFM differ from Guillain–Barré syndrome on examination?
AFM classically shows acute flaccid weakness with spinal anterior horn–predominant MRI lesions and often relatively preserved sensation early; GBS more often follows ascending weakness with areflexia and albuminocytologic dissociation—overlap mandates specialist-led work-up.
Should nurses delay admission while arranging outpatient MRI?
No for suspected AFM: national guidance emphasizes urgent hospital admission, airway-protective monitoring, and expedited neuroimaging rather than outpatient pacing.
What documentation helps public-health case reviewers?
Timestamped weakness distribution, reflex map, cranial nerve findings, preceding viral symptoms, MRI reports and disk images, neurology consultation notes, and logged respiratory parameters.
When should you suspect myasthenic crisis instead of AFM?
Fluctuating fatigable weakness with ptosis, diplopia, or bulbar symptoms in known myasthenia gravis should trigger distinct pathways—but new acute flaccid paralysis still needs emergent evaluation because presentations can be confounded.
- Centers for Disease Control and Prevention. Acute flaccid myelitis (AFM) — main portal.cdc.gov/acute-flaccid-myelitis/index.html
- Centers for Disease Control and Prevention. About acute flaccid myelitis.cdc.gov/acute-flaccid-myelitis/about/index.html
- Centers for Disease Control and Prevention. Clinical overview of AFM (healthcare providers).cdc.gov/acute-flaccid-myelitis/hcp/clinical-overview/index.html
- Centers for Disease Control and Prevention. Clinical testing and diagnosis for acute flaccid myelitis.cdc.gov/acute-flaccid-myelitis/hcp/diagnosis-testing/index.html
- Centers for Disease Control and Prevention. Clinical guidance for the acute medical treatment of AFM.cdc.gov/acute-flaccid-myelitis/hcp/clinical-guidance/index.html
- Centers for Disease Control and Prevention. Case definitions for AFM (surveillance).cdc.gov/acute-flaccid-myelitis/php/reporting-patient/case-definitions.html
- Centers for Disease Control and Prevention. Non-polio enterovirus — overview.cdc.gov/non-polio-enterovirus/index.html
- Yarovaya K, Rayi A. Acute flaccid myelitis. StatPearls (PubMed record).pubmed.ncbi.nlm.nih.gov/39163469
- Murphy OC, Messacar K, et al. Acute flaccid myelitis: cause, diagnosis, and management. Lancet. 2021.pubmed.ncbi.nlm.nih.gov/33357469
- Messacar K, et al. Enterovirus D68 and acute flaccid myelitis — evaluating causality. Lancet Infect Dis. 2018.pubmed.ncbi.nlm.nih.gov/29482893
- Hardy D, Hopkins SE. Update on AFM: recognition, reporting, aetiology, and outcomes. Arch Dis Child. 2020.pubmed.ncbi.nlm.nih.gov/32041735
- Maloney JA, et al. MRI findings in children with acute flaccid paralysis during 2014 enterovirus D68 outbreak. AJNR Am J Neuroradiol. 2015.pubmed.ncbi.nlm.nih.gov/25414005
